Hebei Shengxue Dacheng Pharmaceutical Co., Ltd

Hebei Shengxue Dacheng Pharmaceutical Co., Ltd

specializing in chemical manufacturing

Hebei Shengxue Dacheng Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") was established in 1997. It is a modern pharmaceutical enterprise controlled by China National Nuclear Uranium Co., Ltd., with its headquarters located in Luancheng District, Shijiazhuang City. After...

Read More

Products

Capabilities

  1. Professional Support

    Product selection guidance, volume quotation, sample provision, and technical consultation ensure efficient purchasing decisions.

  2. Reliable Supply Chain

    As a certified manufacturer, we ensure stable chemical inventory, flexible production scheduling, and global logistics support.

  3. Quality and Compliance

    All products meet international standards (ISO, GMP, FCC/USP/EP), with each shipment accompanied by COA, MSDS, and optional TDS.

Hebei Shengxue Dacheng Pharmaceutical Co., Ltd

Culture

Innovation

We continuously develop new chemical solutions and refine processes to meet evolving industry demands.

Sustainability

Our operations prioritize environmental stewardship, responsible sourcing, and long-term resource efficiency.

Reliability

Consistent quality, stable supply, and responsive support ensure our partners can trust us in every project.

News Center

Hebei Shengxue Dacheng Tangshan Pharmaceutical Co., Ltd. Profile

Hebei Shengxue Dacheng Tangshan Pharmaceutical Co., Ltd. (hereinafter referred to as "Tangshan Company") is located in Fengrun District Industrial Zone, Tangshan City, Hebei Province. Founded in August 2006 and covering an area of 110,000 square meters, it is a state-owned high-tech enterprise mainly engaged in the production and sales of pharmaceutical API & preparations as well as feed additives. As a wholly-owned subsidiary of Hebei Shengxue Dacheng Pharmaceutical Co., Ltd., Tangshan Company is a modern pharmaceutical enterprise jointly held by China Uranium Industry Co., Ltd. and Zhejiang Hanye Co., Ltd. The company’s leading products include Colistin Sulfate, Neomycin Sulfate, Spectinomycin Hydrochloride, Colistin Sulfate Premix, Oxytetracycline Calcium Premix, Chlortetracycline Premix and other products. It ranks among the major manufacturers of Colistin Sulfate at home and abroad. Adhering to superior product quality, the company has obtained multiple authoritative certifications, including the ISO9001:2008 Quality Management System Certificate, China Veterinary GMP Certificate, EU CEP Certificate and EU GMP Certificate. Its products are sold nationwide and exported to dozens of countries and regions across Europe, Southeast Asia, America, Africa and beyond, winning wide recognition from global customers. To adapt to evolving market demands, Tangshan Company continuously increases investment in technological innovation, optimizes product quality and develops new products. Meanwhile, it strictly implements environmental management by adhering to the principle of cleaner production and source pollution control, striving to achieve balanced development of economic and environmental benefits. Guided by the mission of Innovating microbial technology, improving people’s quality of life, and safeguarding human health, and upholding the core values of Responsibility, Safety, Innovation and Collaboration, the company keeps enhancing comprehensive competitiveness. It is committed to building a well-known domestic and international enterprise featured with modern microbial technology and specialized chemical pharmaceuticals.

Inner Mongolia Shengxue Dacheng Pharmaceutical Co., Ltd. Profile

Inner Mongolia Shengxue Dacheng Pharmaceutical Co., Ltd. (hereinafter referred to as "Inner Mongolia Company") was established in 2018. It is a modern pharmaceutical enterprise jointly funded by China Uranium Industry Co., Ltd. and Hebei Shengxue Dacheng Pharmaceutical Co., Ltd. (Dacheng Pharmaceutical). The company is located in Kailu County Industrial Park, Tongliao City, Inner Mongolia Autonomous Region. It has a registered capital of 220 million yuan and a total land area of approximately 1,000 mu. The high-end pharmaceutical base project of Inner Mongolia Company is constructed in three phases. Its main construction covers production lines and supporting facilities for Oxytetracycline, Oxytetracycline Hydrochloride, Tetracycline, Streptomycin Sulfate, Dihydrostreptomycin, Neomycin, Minocycline Hydrochloride, Vitamin B2, as well as premixes including Oxytetracycline Calcium, Enramycin, Chlortetracycline, Bacitracin, Nosiheptide and Avilamycin. The Phase I project, with an investment of 1 billion yuan, features an annual output of 5,000 tons of APIs and was completed and put into operation in 2019. The Phase II project is planned to invest 1 billion yuan for a 5,000-ton green animal health product series project, while the Phase III project with an estimated investment of 1 billion yuan focuses on high-end pharmaceutical preparations. Upon full completion and operation of all phases, the company is expected to achieve an annual sales revenue of 3 billion yuan, profits and taxes of 300 million yuan, and provide 2,000 jobs. At present, the Phase I project has been officially commissioned. All core products of the company have passed national GMP certification, national veterinary GMP certification and obtained Japanese official certification. The company’s products sell well across China and are exported to dozens of countries and regions in Europe, America, Southeast Asia, the Middle East, India, North Africa, South America and other areas. It has established long-term strategic cooperative partnerships with global leading pharmaceutical and animal health enterprises including Pfizer, Zoetis, Abbott and Cargill.

Hebei Shengxue Dacheng Pharmaceutical Co.,Ltd

Working at Hebei Shengxue Dacheng Pharmaceutical, life is made up of long hours in noisy plants, daily meetings with the R&D teams, and strong relationships built over the years with people who have a practical commitment to quality. We don’t see shipment numbers or material lots as the end of our job. Each batch characterizes weeks of planning, coordination, and checks that form the backbone of pharmaceutical reliability. It is easy for outsiders to talk about global pharmaceutical supply, but to us, this means raw material contracts checked three times, repeated validation of every step, and a hand-in-glove approach between production and quality control. Mistakes in pharma production cost more than money—they threaten health or lead to interruptions that send ripples across the entire market.Facts from inside make it clear: regulatory updates, especially around GMP compliance, force tough decisions. Updating documentation for a minor enzymatic tweak can tie up resources for a week. A compounding process that looks tidy in a flow chart can cause headaches in a real reactor. For example, the temperature curve demanded by one active ingredient means labor at odd hours and hours lost to chiller maintenance. The hardest part of the job is not just keeping up to code, but anticipating the questions: will this batch meet global market demands, will it pass more scrutiny from our own teams and from external auditors? Local authorities and overseas buyers continuously raise the bar, but we respond by investing in cross-training and strict lot segregation. These aren’t empty buzzwords; to us, a missed temperature hold can lead to a rejected ton and wasted months.Behind every drum and sack leaves a story of close calls, phone calls after dark, and experienced chemists who care about the details no one else sees. Our team shares real-world lessons with every new employee, not just SOPs but stories about what happens if a filter is swapped too soon, or if a validator’s report contains just a single omitted detail. We don’t gloss over the realities of handling sensitive intermediates or the stress of coordinating international shipments under customs scrutiny. Over time, these routines bake a kind of humility into our culture: respect for science, respect for process, and a healthy regard for the trust that clients place in us. A year’s worth of great output can be undone by one careless shortcut, so we foster an environment where accountability flows in every direction—from the boss to the technician and back.The last few years brought clear warnings. Shipping delays, energy price spikes, and global political shifts have forced us to rethink everything from energy use to supplier redundancy. There’s no magic answer. We review alternative solvents, use local suppliers for backup even if they’re pricier, and push for more robust material specs. Stable partnerships with reliable vendors don’t emerge overnight—they grow out of mutual favors, honest conversations about real capabilities (and limitations), and shared responses when something goes sideways. Problems do come fast: if a key raw material fails to clear customs, or if a new environmental rule blocks regular disposal routes, we all feel it by the end of the week. Being on the ground, we react with real-world solutions—modifying shift schedules, working with authorities in person, and investing long term in cleaner, more efficient processes. These aren’t dramatic changes. It means grind and adjustment, often invisible to those on the outside.Numbers mean something to us, but people are the reason things get made right. Veteran staff members know to catch a strange odor before an analyzer gives a number. A sharp-eyed worker can spot discoloration that might mean a contaminant slipped by. Some of the most important fixes in the history of the plant have come from a quick intervention by someone who “knows the line.” Training doesn’t end after a probation period; constant oversight, workshops, and informal discussions make sure lessons from every challenge are shared. This ongoing investment in people is what keeps standards high. Clients can read certifications and audits, but the real assurance comes from the stories behind them: the batch that almost derailed but didn’t, thanks to teamwork and pride in a job done right.Long-term production builds roots in the local community. Emissions control, safe disposal, and occupational health aren’t just about passing inspection but protecting neighbors, families, and colleagues. Energy conservation measures, waste reduction, and local sourcing directly affect those outside our gates. We work with local authorities, not just for compliance, but out of a recognition that the future of the business depends on the health of our surroundings. When someone in town points out a noisy motor or an odd-smelling vent, we don’t brush it off. Those flags spark problem-solving meetings, not just paperwork. This respect is grounded in self-interest—the local pool of talent shapes our technical edge, and our neighbors’ goodwill matters come expansion time or during supply snags. Taking shortcuts on these fronts never pays in the long run.Pharmaceutical manufacturing in Hebei pulls us into every global debate. There’s always pressure to launch new generics faster, source cheaper intermediates, and do more with less energy. Cheap fixes often backfire and drag down reputations. Real innovation, the kind customers notice, means slow, steady upgrades and careful investment in new lines and technology. The toughest challenges arrive late at night, through problem reports or messages from labs that found something off. In those moments, we fall back on experience and honest teamwork, not just protocols. The world’s expectations grow every year, but so does our pride in holding the line on true quality. We know our work shapes both the lives of clients far away and families close to home.